Search
Now showing items 1-1 of 1
Pembrolizumab Induced Tumor Shrinkage in Rare Osseous Metastasis of Basal Cell Carcinoma
(2023-07-31)
Cutaneous basal cell carcinoma (BCC) is an
increasingly common malignancy with a rising
incidence over the past decade. 1 BCC seldom
exhibits lymphatic or hematogenous metastasis with
an incidence of only 0.0028% ...